Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Iacono D, Raimondi M, Marino V, Riccio F, Marchesano ML, Milone A, Corrado A, Rotondo C, Firenze I, La Barbera L, Rizzo C, Montalbano S, Navarini L, Lo Gullo A, Oliva M, Favoino E, Orlando I, Cantatore FP, Cipriani P, Tirri E, Giacomelli R, Perosa F, Guggino G, Ruscitti P, Ciccia F

Open source

DOI
10.1007/s10067-026-08373-8
Published
2026 Nov
Container
Clinical rheumatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10067-026-08373-8,
  title = {Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.},
  author = {Iacono D and Raimondi M and Marino V and Riccio F and Marchesano ML and Milone A and Corrado A and Rotondo C and Firenze I and La Barbera L and Rizzo C and Montalbano S and Navarini L and Lo Gullo A and Oliva M and Favoino E and Orlando I and Cantatore FP and Cipriani P and Tirri E and Giacomelli R and Perosa F and Guggino G and Ruscitti P and Ciccia F},
  year = {2026},
  journal = {Clinical rheumatology},
  doi = {10.1007/s10067-026-08373-8},
  url = {https://doi.org/10.1007/s10067-026-08373-8}
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
AU  - Iacono D
AU  - Raimondi M
AU  - Marino V
AU  - Riccio F
AU  - Marchesano ML
AU  - Milone A
AU  - Corrado A
AU  - Rotondo C
AU  - Firenze I
AU  - La Barbera L
AU  - Rizzo C
AU  - Montalbano S
AU  - Navarini L
AU  - Lo Gullo A
AU  - Oliva M
AU  - Favoino E
AU  - Orlando I
AU  - Cantatore FP
AU  - Cipriani P
AU  - Tirri E
AU  - Giacomelli R
AU  - Perosa F
AU  - Guggino G
AU  - Ruscitti P
AU  - Ciccia F
PY  - 2026
JO  - Clinical rheumatology
DO  - 10.1007/s10067-026-08373-8
UR  - https://doi.org/10.1007/s10067-026-08373-8
ER  - 

APA

D, I., M, R., V, M., F, R., ML, M., A, M., A, C., C, R., I, F., L, L. B., C, R., S, M., L, N., A, L. G., M, O., E, F., I, O., FP, C., P, C., E, T., R, G., F, P., G, G., P, R., & F, C. (2026). Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.. Clinical rheumatology. https://doi.org/10.1007/s10067-026-08373-8

Source records